Medcaw Investments Plc First Day of Dealings on the London Stock Exchange

 
TIDMMCI 
 
Not for release or distribution, directly or indirectly, within, into or in the 
United States or to or for the account or benefit of persons in the United 
States, Australia, Canada, Japan or any other jurisdiction where such offer or 
sale would violate the relevant securities laws of such jurisdiction 
 
                            MEDCAW INVESTMENTS PLC 
 
                            ("Company" or "Medcaw") 
 
              First Day of Dealings on the London Stock Exchange 
 
Medcaw Investments plc, a company formed for the purpose of undertaking an 
acquisition or acquisitions in the life sciences sector life sciences sector, 
focusing on companies developing medical or wellness technologies and 
therapies, is pleased to announce that, following the publication of its 
Prospectus on 16 December 2022, a total of 17,132,095 ordinary shares of £0.01 
each in the share capital of the Company will today be admitted to the standard 
segment of the Official List of the Financial Conduct Authority and to trading 
on the main market for listed securities of the London Stock Exchange plc. 
 
Dealings will commence at 8:00 a.m. today under the TIDM 'MCI' with ISIN number 
GB00BM8SQP62 and SEDOL BM8SQP6. 
 
Enquiries 
 
Medcaw Investments Plc                                [phone] 
Sarah Cope 
Executive Chairperson 
 
Arden Partners Plc 
Ruari McGirr                                           [phone] 
Alexandra Campbell-Harris 
 
 
 
 
END 
 
 

(END) Dow Jones Newswires

December 21, 2022 03:00 ET (08:00 GMT)